These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
14. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?]. Baumann M Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558 [No Abstract] [Full Text] [Related]
15. [The role of adjuvant chemotherapy in the treatment of early stage NSCLC after radical surgery]. De Marinis F; De Petris L Suppl Tumori; 2004; 3(4):S50-1. PubMed ID: 15206212 [No Abstract] [Full Text] [Related]
20. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941? Van Meerbeeck JP; De Pauw R; Tournoy K Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]